Zantac Liver Cancer

If you regularly used Zantac to treat your heartburn, GERD, or related health condition and have since been diagnosed with liver cancer, there may be a connection. The Food and Drug Administration (FDA) recently pulled Zantac and other ranitidine medications from the market because of the connection between a contaminate found in the medications – NDMA (N-Nitrosodimethylamine) – and a variety of cancers, including liver cancer.

Probable Carcinogen

Several national and international health organizations have deemed NDMA a probable carcinogen or cancer-causing agent. These organizations include all of the following:

• The Environmental Protection Agency (EPA)
• The World Health Organization (WHO)
• The International Agency for Research on Cancer (IARC)

Liver Cancer

Liver cancers begin in the cells of the liver, and those affected are often symptom-free until the disease progresses – according to the Mayo Clinic. Because early diagnosis is closely associated with improved prognosis, this makes liver cancer an even more serious disease. Those symptoms associated with the disease’s progression include:

• Nausea and/or vomiting
• An unintentional loss of weight
• Loss of appetite
• Abdominal swelling
• General weakness and overall fatigue
• Stools that are white and chalky
• A yellow discoloration of the skin and the whites of the eyes (jaundice)

It’s Time to Consult with an Experienced Drug Injury Lawyer

If you took Zantac regularly and have been diagnosed with liver cancer, holding the drug company accountable is important, and a dedicated drug injury lawyer can help. Obtaining the compensation to which you are entitled is the best path forward.